US and Europe Surrogacy Market is expected reach US$ 25,284.02 million by 2030

Gestational Surrogacy Segment to Lead US and Europe Surrogacy Market During 2022–2030

According to our new research study on “US and Europe Surrogacy Market Forecast to 2030 – COVID-19 Impact and Regional Analysis – by Type, Age Group, and Service Order,” the US and Europe surrogacy market is expected to grow from US$ 6,113.72 million in 2022 to US$ 25,284.02 million by 2030; it is estimated to register a CAGR of 19.4% during 2022–2030. Key factors driving the US and Europe surrogacy market growth include the increasing cases of infertility and growing awareness of the treatment of fertility.

Based on type, the US and Europe surrogacy market is bifurcated gestational surrogacy and traditional surrogacy. The gestational surrogacy segment held a larger share of the market in 2022 and is anticipated to register a CAGR of 19.6% in the market during the forecast period. The US and Europe surrogacy market growth for this segment is attributed to the increasing acceptance and awareness among couples unable to conceive naturally. The legalization of gestational surrogacy in the US and European countries such as the Netherlands, Portugal, and Russia; and changing social perspectives in these countries favor the growth of the market for the gestational surrogacy segment. The US and Europe surrogacy market, based on service order, is segmented into hospitals, fertility clinics, and others. In 2022, the fertility clinics segment held the largest US and Europe surrogacy market share, and the same is expected to grow at the fastest CAGR during the forecast period. Fertility clinics are preferred for surrogacy as they have specialized medical expertise and infrastructure for handling complex procedures, such as IVF and IUI. Fertility clinics also focus on providing legal advice and consultation to the intended parents so that they get a clear idea of the process of surrogacy. Therefore, the cost of treatment in fertility clinics is much higher than in hospitals.

US and Europe Surrogacy Market, by region, 2022 (%)

To get free sample copy of the report, along with the TOC, Statistics, and Tables please visit @ https://www.theinsightpartners.com/sample/TIPRE00029965

Source: The Insight Partners Analysis

Impact of COVID-19 Pandemic on US and Europe Surrogacy Market

The COVID-19 pandemic led to both public health and economic crises across the world. The global economy experienced a decline in the performance of almost all industries. The COVID-19 pandemic has had a significant impact on the surrogacy market in both the US and Europe, leading to notable changes and challenges, mainly due to the disruption caused by travel restrictions and border closures. International surrogacy arrangements were significantly disturbed, as intended parents faced difficulties traveling to the surrogate's location for medical processes and legal proceedings; they also failed to be present for the birth of their child. This resulted in delays and logistical complications for the intended parents.

Adaptation to health and safety protocols, relaxations in travel restrictions, and the implementation of virtual technologies for medical consultations and legal proceedings in late 2020 facilitated the recovery of the US and Europe surrogacy market. However, the long-term impact of the pandemic on the surrogacy market is likely to continue as the industry continues to navigate through the ongoing challenges and adapt to the changing circumstances.

London Women's Clinic Ltd, The Centre for Reproductive and Genetic Health Ltd, Miracle Baby Surrogacy, Lotus Surrogacy, VittoriaVita LLC, Sensible Surrogacy, New Life Ukraine, Redia Ltd, Circle Surrogacy LLC, and Ovation Fertility are among the leading companies operating in the US and Europe surrogacy market.

The US and Europe surrogacy market is segmented on the basis of type, technology, age group, and service orders. By type, the market is segmented into gestational surrogacy and traditional surrogacy. Based on age group, the US and Europe surrogacy market is segmented into below 35 Years, 35–37 Years, 38–39 Years, 40–42 Years, 43–44 Years, and over 44 Years. The US and Europe surrogacy market, by technology, is classified into intrauterine insemination (IUI) and in-vitro fertilization (IVF). By service order, the US and Europe surrogacy market is segmented into hospitals, fertility clinics, and others. In terms of geography, the US and Europe surrogacy market is segmented into the US and Europe (Italy, UK, Denmark, Netherlands, Irelands, and Rest of Europe).

Contact Us
Contact Us: The Insight Partners 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com